GlassScriptPhysician profile
Anderson Hu
NPI 1902170673
$3,880.93
in general payments reported to CMS, 2019-2025
7 companies · $190 in 2025
The $190 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $787 · 2023: $13.20 · 2024: $2,890 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,840 · Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,840.00 |
| Food and Beverage | $253.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $2,840.00 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $787.22 | 2021 | |
| Acera Surgical, INC. | $157.20 | 2025 | Restrata Wound Matrix |
| Edwards Lifesciences Corporation | $50.30 | 2024 | Hemosphere |
| Heron Therapeutics, INC. | $18.19 | 2025 | Aponvie |
| Boston Scientific Corporation | $14.82 | 2025 | Overstitch Endoscopic Suturing System |
| Haemonetics Corporation | $13.20 | 2023 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anderson Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.